We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The American Medical Association (AMA) is recommending that the FDA set a temporary moratorium on direct-to-consumer (DTC) advertising of prescription drugs, a suggestion that industry representatives reject.
The FDA is urging drugmakers to eliminate unclear medication abbreviations from drug labeling, packaging and advertising as part of an educational campaign that aims to prevent patient harm caused by medication errors.
A federal judge has ruled that Tercica’s false advertising lawsuit against Insmed is without grounds because the comments in question were made to investors and not consumers.
A group of 39 medical, seniors' and health organizations have asked Congress to pass legislation ending or altering the practice of direct to consumer (DTC) prescription drug ads.
A group of 39 medical, seniors’ and health organizations have asked Congress to pass legislation ending or altering the practice of direct to consumer (DTC) prescription drug ads.
PhRMA will use an independent direct-to-consumer (DTC) ad review panel to address healthcare providers’ concerns with such ads, PhRMA President Billy Tauzin said.
A coalition of advertising and public relations groups wants the FDA to establish a new advisory committee to address issues associated with Rx drug marketing and overhaul its rules on direct-to-consumer (DTC) advertising.
Pfizer is facing a federal class action lawsuit alleging the company defrauded insurance plans and the federal government by improperly marketing its top-selling Lipitor.
AstraZeneca is under investigation by the U.S. Attorney’s Office in Los Angeles for its field promotional activities, according to the company’s annual SEC filing.
Congress should pass legislation that would encourage the creation of new antibiotics to fight drug-resistant germs, according to an article in the current issue of Clinical Infectious Diseases.